RXRX
|
Recursion Pharmaceuticals, Inc.
|
0.97%
|
US
|
NASDAQ
|
2252
|
Shanghai MicroPort MedBot Group Co Ltd
|
0.97%
|
HK
|
HK
|
PHR
|
Phreesia, Inc.
|
0.97%
|
US
|
NYSE
|
BIM
|
Biomerieux SA
|
0.97%
|
FR
|
PA
|
SAGE
|
Sage Therapeutics, Inc.
|
0.96%
|
US
|
NASDAQ
|
QGEN
|
Qiagen N.V.
|
0.96%
|
US
|
NYSE
|
PODD
|
Insulet Corporation
|
0.96%
|
US
|
NASDAQ
|
RMD
|
ResMed Inc.
|
0.96%
|
US
|
NYSE
|
PEN
|
Penumbra, Inc.
|
0.96%
|
US
|
NYSE
|
VEEV
|
Veeva Systems Inc.
|
0.95%
|
US
|
NYSE
|
NKTR
|
Nektar Therapeutics
|
0.95%
|
US
|
NASDAQ
|
FOLD
|
Amicus Therapeutics, Inc.
|
0.95%
|
US
|
NASDAQ
|
BIIB
|
Biogen Idec Inc.
|
0.95%
|
US
|
NASDAQ
|
ARCT
|
Arcturus Therapeutics Ltd.
|
0.95%
|
US
|
NASDAQ
|
0241
|
Alibaba Health Information Technology Ltd
|
0.94%
|
HK
|
HK
|
RGNX
|
REGENXBIO Inc.
|
0.93%
|
US
|
NASDAQ
|
ONEM
|
1Life Healthcare, Inc.
|
0.93%
|
US
|
NASDAQ
|
ISRG
|
Intuitive Surgical, Inc.
|
0.93%
|
US
|
NASDAQ
|
GMED
|
Globus Medical, Inc.
|
0.93%
|
US
|
NYSE
|
BSX
|
Boston Scientific Corporation
|
0.93%
|
US
|
NYSE
|